Inhibition of the EP300 /Notch Signaling Pathway Regulates Proliferation and Apoptosis in Oral Squamous Cell Carcinoma
Journal of Oral Pathology & Medicine · 2026
DOI: 10.1111/jop.70159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2026. Verfasst von Honglan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China. Hauptthemen laut MEDLINE: Apoptosis, Mouth Neoplasms, Carcinoma, Squamous Cell, Signal Transduction. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Affiliated Hospital of North Sichuan Medical College, North Sichuan Medical College.
Abstract (Originalsprache)
Objective
Oral squamous cell carcinoma (OSCC) is highly recurrent and metastatic; EP300 drives tumorigenesis, but its mechanism is unclear. Materials and Methods EP300 expression was profiled in OSCC via databases, RT‐PCR, and Western blot. Knockdown effects on proliferation (CCK‐8, colony), cell cycle, and apoptosis (flow cytometry) were measured. EP300–Notch interplay was probed with Valproic acid, a Notch signaling activator (VPA) rescue assays.
Results
Our experimental results showed that EP300 was upregulated in OSCC Cell Lines. In addition, bioinformatics analysis showed that EP300 upregulation was significantly associated with poor prognosis of OSCC . Prior research and bioinformatics analyses have demonstrated a close relationship between EP300 and the activation of the notch signaling pathway in OSCC . After EP300 knockdown in OSCC cells treated with VPA , our results indicated that VPA could partially reverse the effects of EP300 knockdown on cell proliferation, cell cycle, apoptosis, and EMT processes in OSCC Cells.
Conclusion
In this study, we observed that EP300 knockdown suppressed the Notch signaling pathway, consequently inhibiting OSCC cell proliferation, the cell cycle, and EMT while also promoting apoptosis. These findings suggest that EP300 is crucial for OSCC cell growth and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
- Department of Stomatology, North Sichuan Medical College, Nanchong, China.
- Pingyang County Hospital of Traditional Chinese Medicine, Wenzhou, China.
- Department of Stomatology, Cangnan People's Hospital, Wenzhou, China.
- Department of Jiaxing Dental Hospital, Jiaxing, Zhejiang, China.
- Department of Clinical Medicine, North Sichuan Medical College, Nanchong, China.
Förderung
- the Affiliated Hospital of North Sichuan Medical College
- North Sichuan Medical College
Zitieren
APA
Wang, H., Fu, Y., Lin, G., Zhang, D., Nan, X., Liu, J., Mou, X., Liu, C., Fan, Y., Zheng, T., & Liu, Y. (2026). Inhibition of the EP300 /Notch Signaling Pathway Regulates Proliferation and Apoptosis in Oral Squamous Cell Carcinoma. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.70159
Vancouver
Wang H, Fu Y, Lin G, Zhang D, Nan X, Liu J, et al. Inhibition of the EP300 /Notch Signaling Pathway Regulates Proliferation and Apoptosis in Oral Squamous Cell Carcinoma. Journal of Oral Pathology & Medicine. 2026. doi:10.1111/jop.70159
BibTeX
@article{Wang2026,
author = {Wang, Honglan and Fu, Yanzhen and Lin, Gaoren and Zhang, Dandan and Nan, Xiaoxu and Liu, Jiaming and Mou, Xuelin and Liu, Changyue and Fan, Yuxuan and Zheng, Tong and Liu, Ying},
title = {Inhibition of the EP300 /Notch Signaling Pathway Regulates Proliferation and Apoptosis in Oral Squamous Cell Carcinoma},
journal = {Journal of Oral Pathology & Medicine},
year = {2026},
doi = {10.1111/jop.70159}
}
EUVIMED